Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HR+/HER2- Breast Cancer × 130-nm albumin-bound paclitaxel × 90 days × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 20 Carcinoma, Non-Small-Cell Lung 20 Breast Neoplasms 14 Lung Neoplasms 11 Triple Negative Breast Neoplasms 9 Neoplasm Metastasis 8 Colorectal Neoplasms 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Neoplasms 4 Carcinoma, Pancreatic Ductal 4 Stomach Neoplasms 3 Ovarian Neoplasms 3 Fallopian Tube Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Pancreatic Ductal Adenocarcinoma 2 Gastrointestinal Neoplasms 2 Gallbladder Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Endometrial Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2 Carcinoma 2 Adenocarcinoma 2 Vaccinia 1 Uveal Melanoma 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Thymic epithelial tumor 1

Interventions

Letrozole 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡